Projekte
Suche in 1164 Projekten:
1164 Projekt(e)
HIT-Studie
01.02.2021Targeted correction of plasma sodium levels in hospitalized patients with hyponatremia: a randomized, controlled, parallel-group trial with blinded outcome assessment
Klinische Forschung - 01.02.2021 - 31.12.2025
Laufend
Projektleitung: Bilz Stefan
Mitarbeiter/innen: Bontognali Martina, Räss Andrea, Rothlin Silvia, Grillmayr Victoria
I6T-MC-AMBI
01.02.2021A Phase 3b, Randomized, Double-Blind, Parallel-Arm, Placebo- and Active- Controlled Treat-Through Study of Mirikizumab and Vedolizumab in participants with Moderately to Severely Active Ulcerative Colitis
Klinische Forschung - 01.02.2021 - 01.01.2024
Abgeschlossen
Projektleitung: Brand Stephan
Mitarbeiter/innen: Smolders Jolijn, Krieger-Grübel Claudia
Development of the European Organisation for Research and Treatment of Cancer (EORTC)/ Cutaneous Lymphoma Task Force (CLTF) questionnaire to assess HRQoL in cutaneous lymphoma
01.02.2021
Klinische Forschung - 01.02.2021 - 25.08.2023
Automatisch geschlossen
Projektleitung: Cozzio Antonio
RECOVER: Rheumatoid Covid-19 Vaccine Immune Response
01.02.2021Untersuchung der Sicherheit und Effektivität von mRNA basierten COVID-19 Impfungen bei Patienten mit rheumatoider Arthritis - ein exploratives Forschungsprojekt
Klinische Forschung - 01.02.2021 - 31.12.2022
Abgeschlossen
Projektleitung: Rubbert-Roth Andrea
Mitarbeiter/innen: Schmiedeberg Kristin, Bartz-Batliner Mira, Peischl Riana, Peischl Shirin, Sasselli Clelia, Hutz Carina Liane
I6T-MC-AMAP
29.01.2021A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis LUCENT 3
Klinische Forschung - 29.01.2021 - 01.12.2024
Laufend
Projektleitung: Brand Stephan
Mitarbeiter/innen: Krieger-Grübel Claudia, Smolders Jolijn
VitCov Studie
25.01.2021High Dose Vitamin-D-substitution in Patients with COVID-19: a randomized, double blind, placebo controlled, multi-centre Study. The objective of the study is to test the hypothesis that patients with vitamin D deficiency suffering from COVID-19 trea...
Klinische Forschung - 25.01.2021 - 31.12.2021
Automatisch geschlossen
Projektleitung: Brändle Michael
Mitarbeiter/innen: Bloch Nando, Räss Andrea
ESSENCE
01.01.2021
Klinische Forschung - 01.01.2021 - 31.12.2026
Laufend
Projektleitung: Bilz Stefan
Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: the ERYT/CoordiFit randomized controlled trial
01.01.2021Background: Cancer-related fatigue (CRF) is the most taxing symptom for many breast cancer patients during and after therapy. In patients with metastatic disease, the prevalence of CRF exceeds 75%. Currently, there is no gold standard for the treatme...
Klinische Forschung - 01.01.2021 - 31.12.2024
Abgeschlossen
Projektleitung: Schlaeppi Marc
Resistance Development in Escherichia coli at different pH following Delafloxacin and Ciprofloxacin Challenge
01.01.2021Delafloxacin , a novel dual-targeting non-zwitterionic fluoroquinolone, has received approval by the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of acute bacterial skin and skin structure infectio...
Grundlagenforschung - 01.01.2021 - 01.01.2023
Automatisch geschlossen
Projektleitung: Babouee Flury Baharak
Translation of pre-treatment tumor kinetics and clinical and serological markers of the immune system in the treatment of advanced melanoma
01.01.2021Bei diesem Projekt geht es um die Charakterisierung des Therapieansprechens von Melanommetastasen unter Systemtherapie mit anti-PD-1 Antikörpern, kombinierter Immuntherapie mit dem anti-PD-1 Antikörper Nivolumab und dem anti-CTLA-4 Antikörper Ipilimu...
Klinische Forschung - 01.01.2021 - 31.12.2021
Abgeschlossen
Projektleitung: Wagner Nikolaus
Decision-Making Analysis of next generation sequencing in glioblastoma in Switzerland
01.01.2021Glioblastoma is the most frequent and most malignant primary brain tumour with an annual incidence of 3.2/100’000 1,2. The combination of histopathological features (nuclear atypia, mitosis, neoangiogenesis and/or necrosis) and molecular aberrations...
Klinische Forschung - 01.01.2021 - 01.12.2021
Automatisch geschlossen
Mitarbeiter/innen: Putora Paul Martin
Towards identification of novel therapeutic targets: Assessment of proteasome-related alterations in MM patients’ datasets
01.01.2021
Grundlagenforschung - 01.01.2021 - 31.12.2021
Automatisch geschlossen
Projektleitung: Besse Lenka, Buljan Marija
Mitarbeiter/innen: Besse Andrej
Clinical evaluation of a standard treatment algorithm for midshaft clavicle fractures
01.01.2021The aim of this research project is to evaluate the evidence-based treatment standard for patients with midshaft clavicle fractures using an algorithmic approach in a Swiss multi-centre, prospective data collection. This algorithm includes not only t...
Register - 01.01.2021 - 31.12.2025
Laufend
Projektleitung: Spross Christian
Mitarbeiter/innen: Jost Bernhard, Zdravkovic Vilijam, Schöfl Thomas, Farei-Campagna Jan M
Diagnostic role of the "white test" with lipidic solution in the early intraoperative identification of open bile ducts for the prevention of bile leakage after liver resection - A randomized controlled multicentric superiority trial.
01.01.2021Bile leakage (BL) is the most frequent complication after liver resection leading to the need of interventional drainage, ERCP or even reoperation. Strategies leading to a reduction of the rate of this complication are valuable. SMOFlipid 20% is a fa...
Klinische Forschung - 01.01.2021 - 31.12.2024
Laufend
Projektleitung: Tarantino Ignazio
Mitarbeiter/innen: Seiler Edith
Swiss Soliris® and Ultomiris® Reimbursement Registry SSURR: An observational registry for capturing data of patients suffering from paroxysmal nocturnal hemoglobinuria (PNH) who are treated with Soliris® (eculizumab) or Ultomiris® (ravulizumab)
01.01.2021
Klinische Forschung - 01.01.2021 - 31.12.2030
Laufend
Projektleitung: Silzle Tobias
Mitarbeiter/innen: Demmer-Steingruber Ruth, Müller Fiona
Swiss Primary Hypersomnolence and Narcolepsy Cohort Study
01.01.2021
Klinische Forschung - 01.01.2021 - 31.12.2023
Abgeschlossen
Projektleitung: Von Manitius Sigrid
Mitarbeiter/innen: Zieglgänsberger Dominik, Gievers-Steinlein Bettina
CATCH - Cascade genetic testing of familial hypercholesterolemia: the CATCH multicenter randomized controlled trial
15.12.2020To test in a multicenter open-label randomized controlled trial across Switzerland whether a cascade screening programme for FH, in comparison with usual care, will increase the detection rate of FH within families. The primary outcome will be the...
Klinische Forschung - 15.12.2020 - 31.03.2024
Abgeschlossen
Projektleitung: Rickli Hans
Mitarbeiter/innen: Vetsch Susanne, Schneider Irene
SILENT 2
04.12.2020Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions Arterial Fibrillation (AF) is well-recognized as a cause for cryptogenic Acute Ischemic Stroke (AIS) and is associated with Silent Brain Infarction...
Klinische Forschung - 04.12.2020 - 04.12.2024
Laufend
Projektleitung: Ammann Peter, Kägi Georg
Mitarbeiter/innen: Brenner Roman, Vetsch Susanne, Schneider Irene
Smartphone-Enabled Detection of COugh in COvid-19 (COCO): An Exploratory, Single-Center, Observational Cohort Study
03.12.2020
Klinische Forschung - 03.12.2020 - 03.12.2020
Automatisch geschlossen
Projektleitung: Rassouli Frank
Mitarbeiter/innen: Bösch Maximilian, Brutsche Martin, Tinschert Peter, Barata Filipe, Shih Iris
Validation of a textile-based monitoring device for the continuous surveillance of respiratory activity in patients during sedation
01.12.2020
Klinische Forschung - 01.12.2020 - 30.11.2021
Automatisch geschlossen